10.1111/adb.12295 73 VallofD.VestlundJ.JerlhagE
At ACR Convergence 2025, researchers from Toronto and NYU reported that PsA patients starting GLP-1 receptor agonists had significant improvements in joint counts, CRP, pain scores, and DAPSA disease activity scores within one year of treatment. Whats interesting is that you dont seem to need a large dose to see these benefits
As researchers explore its profound effects on weight management and glycemic control, a crucial question keeps surfacing, one that touches on the fundamental safety and physiological profile of the compound: does retatrutide raise heart rate
How can I tell if my GLP-1 medication dosage needs to be adjusted
Shipping Orders ship within the United States via USPS
Abstract Accumulating evidence suggests that metabolic demands of the regenerating liver are met via lipid metabolism and critical regulators of this process